We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00078143
Recruitment Status : Completed
First Posted : February 23, 2004
Last Update Posted : January 12, 2017
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.

Condition or disease Intervention/treatment Phase
Substance-Related Disorders Behavioral: Behavior Therapy Phase 3

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Primary Purpose: Treatment
Official Title: Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users
Study Start Date : October 2003
Primary Completion Date : April 2006
Study Completion Date : April 2006

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions


Outcome Measures

Primary Outcome Measures :
  1. Treatment Utilization
  2. Substance Abuse

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Pregnancy <30 weeks
  • Have not attended drug treatment in past 28 days
  • Not needing residential treatment (except detox)
  • Not at risk for suicide/homicide
  • Have no pending legal charges (except drug treatment)
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00078143


Locations
United States, Indiana
Midtown Community Mental Health Center
Indianapolis, Indiana, United States, 46202
United States, Kentucky
Jefferson Alcohol & Drug Abuse Center
Louisville, Kentucky, United States, 40202
United States, Michigan
Eleonore Hutzel Recovery Center
Detroit, Michigan, United States, 48201
United States, New Mexico
Milagro Clinic
Albuquerque, New Mexico, United States, 87106
Milagro
Albuquerque, New Mexico, United States, 87106
United States, North Carolina
Coastal Horizons Center, Inc.
Wilmington, North Carolina, United States, 28412
Sponsors and Collaborators
University of Cincinnati
Investigators
Principal Investigator: Theresa Winhusen, Ph.D. University of Cincinnati
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Theresa Winhusen, Ph.D., University of Cincinnati
ClinicalTrials.gov Identifier: NCT00078143     History of Changes
Other Study ID Numbers: NIDA-CTN-0013-1
First Posted: February 23, 2004    Key Record Dates
Last Update Posted: January 12, 2017
Last Verified: October 2016

Keywords provided by National Institute on Drug Abuse (NIDA):
behavioral intervention

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders